Frequent Adverse Drug Reactions, and Medication Groups under Suspicion
Dtsch Arztebl Int 2018; 115: 393-400. DOI: 10.3238/arztebl.2018.0393
Figure 1
Figure 2
Figure 3
Key messages
Table 1
Table 2
eBox 1
eBox 2
eBox 3
eFigure 1
eFigure 2
eFigure 3
eTable 1
eTable 2
eTable 3
